The COVID-19 crisis is causing a surge in interest in ‘virtual trials’ where the ... director of data management and metrics for Vertex Pharmaceuticals, told the conference that the COVID ...

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...